Haleon plc (NYSE:HLN) Stock Holdings Trimmed by Riverbridge Partners LLC

Riverbridge Partners LLC decreased its holdings in Haleon plc (NYSE:HLN) by 30.1% in the 4th quarter, HoldingsChannel reports. The firm owned 15,363 shares of the company’s stock after selling 6,628 shares during the quarter. Riverbridge Partners LLC’s holdings in Haleon were worth $147,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of HLN. FMR LLC grew its position in Haleon by 5.8% in the 3rd quarter. FMR LLC now owns 104,918,269 shares of the company’s stock valued at $1,110,035,000 after buying an additional 5,768,117 shares in the last quarter. Clearbridge Investments LLC lifted its stake in shares of Haleon by 8.6% in the 2nd quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock worth $344,888,000 after acquiring an additional 3,307,009 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Haleon by 49.9% in the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock valued at $96,833,000 after acquiring an additional 3,046,841 shares in the last quarter. Sculptor Capital LP increased its stake in shares of Haleon by 67.8% during the second quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock valued at $73,407,000 after acquiring an additional 3,592,000 shares during the period. Finally, Douglas Lane & Associates LLC raised its holdings in Haleon by 1.9% during the fourth quarter. Douglas Lane & Associates LLC now owns 8,624,149 shares of the company’s stock worth $82,274,000 after purchasing an additional 161,865 shares in the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HLN has been the topic of several research analyst reports. UBS Group upgraded Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Finally, Morgan Stanley downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $10.95.

Haleon Price Performance

Shares of NYSE:HLN opened at $9.40 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The company has a market capitalization of $42.53 billion, a PE ratio of 27.63, a price-to-earnings-growth ratio of 2.62 and a beta of 0.29. The stock has a fifty day moving average of $9.54 and a 200-day moving average of $9.72. Haleon plc has a one year low of $7.89 and a one year high of $10.80.

Haleon (NYSE:HLN) last announced its earnings results on Thursday, October 31st. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.11 by $0.03. The business had revenue of $3.62 billion during the quarter, compared to the consensus estimate of $3.74 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. During the same period in the prior year, the business posted $0.10 earnings per share. As a group, equities analysts anticipate that Haleon plc will post 0.44 EPS for the current fiscal year.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.